Rare immune-mediated pneumonitis in association with post-streptococcal glomerulonephritis

被引：0
作者：
Wiles, Kate S. [1 ]
Lee, Mihye [2 ]
Brindle, Richard [2 ]
Railton, Nicholas J. [3 ]
Clark, Robin J. [4 ]
Poller, David N. [5 ]
Mason, Juan C. [1 ]
机构：
[1] Portsmouth Hosp NHS Trust, Queen Alexandra Hosp, Wessex Renal & Transplant Unit, Portsmouth, Hants, England
[2] Portsmouth Hosp NHS Trust, Queen Alexandra Hosp, Dept Microbiol, Portsmouth, Hants, England
[3] Portsmouth Hosp NHS Trust, Queen Alexandra Hosp, Dept Radiol, Portsmouth, Hants, England
[4] Portsmouth Hosp NHS Trust, Queen Alexandra Hosp, Dept Resp Med, Portsmouth, Hants, England
[5] Portsmouth Hosp NHS Trust, Queen Alexandra Hosp, Dept Histopathol, Portsmouth, Hants, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2011年 / 26卷 / 12期
关键词：
glomerulonephritis; pneumonitis; post-streptococcal; ARTHRITIS;
D O I：
10.1093/ndt/gfr526
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
We describe the case of a 48-year-old man with an acute nephritis and respiratory failure. Clinical history, streptococcal antibody titres and renal biopsy led to a diagnosis of post-streptococcal glomerulonephritis. Respiratory investigations excluded pulmonary oedema and infection. We hypothesize that this man had a co-existing post-streptococcal glomerulonephritis and an immune-mediated pneumonitis. This is a very rare association, which was last described in 1982.
引用
收藏
页码：4140 / U350
页数：3
相关论文
共 43 条
  • [41] Characterizing immune-mediated adverse events with durvalumab in patients with unresectable stage III NSCLC: A post-hoc analysis of the PACIFIC trial
    Naidoo, Jarushka
    Vansteenkiste, Johan F.
    Faivre-Finn, Corinne
    Ozguroglu, Mustafa
    Murakami, Shuji
    Hui, Rina
    Quantin, Xavier
    Broadhurst, Helen
    Newton, Michael
    Thiyagarajah, Piruntha
    Antonia, Scott J.
    LUNG CANCER, 2022, 166 : 84 - 93
  • [42] Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
    Suarez-Almazor, Maria E.
    Pundole, Xerxes
    Abdel-Wahab, Noha
    Johnson, Douglas B.
    Gupta, Dipti
    Glezerman, Ilya
    Cooksley, Tim
    Anderson, Ronald
    Blidner, Ada
    Choi, Jennifer
    Dougan, Michael
    Ginex, Pamela
    Girotra, Monica
    Shannon, Vickie R.
    Rapoport, Bernardo L.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 6159 - 6173
  • [43] Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
    Maria E. Suarez-Almazor
    Xerxes Pundole
    Noha Abdel-Wahab
    Douglas B. Johnson
    Dipti Gupta
    Ilya Glezerman
    Tim Cooksley
    Ronald Anderson
    Ada Blidner
    Jennifer Choi
    Michael Dougan
    Pamela Ginex
    Monica Girotra
    Vickie R. Shannon
    Bernardo L. Rapoport
    Supportive Care in Cancer, 2020, 28 : 6159 - 6173
12345